Anticoagulation in patients with cirrhosis and portal vein thrombosis: Safety and beneficial effect on OLT-free survival

Liver Int. 2019 Oct;39(10):2002. doi: 10.1111/liv.14231. Epub 2019 Sep 18.

Authors

Carlos Noronha Ferreira^{1

2}, Helena Cortez-Pinto^{1

2}, Fátima Serejo^{1

2}, José Velosa^{1

2}, Rui Tato Marinho^{1

2}

Affiliations

¹ Serviço de Gastrenteroogia e Hepatologia, Hospital de Santa Maria, Centro Hospitalar Universitário, Lisbon, Portugal.
² Clínica Universitária de Gastrenterologia, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.

PMID: 31461802
DOI: 10.1111/liv.14231

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants
Humans
Incidence
Liver Cirrhosis*
Portal Vein*
Prospective Studies

Substances

Anticoagulants